FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Capillary Bio Wearable Infusion Set Cleared

FDA clears a Capillary Biomedical 510(k) for its SteadiSet, a wearable infusion set that delivers insulin from a pump to the body for up to three days...

latest-news-card-1
Medical Devices

GEs Optison OKd for Pediatric Heart Imaging

FDA approves GE HealthCares ultrasound imaging agent Optison 9 for use in pediatric patients.

latest-news-card-1
Human Drugs

Indian API Maker Hit with Warning Letter

FDA sends Indian active pharmaceutical ingredient manufacturer Mentha & Allied Products a Warning Letter that cites the firm for significant GMP viola...

latest-news-card-1

FDA Wants Public Deregulation Input

FDA and HHS ask public stakeholders for their ideas on regulations that should be eliminated.

latest-news-card-1
Human Drugs

CGMP Violations at Excelvision Fareva

FDA warns Frances Excelvision Fareva about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

FDA Moves to Ban Pediatric Ingestible Fluoride Drugs

FDA plans to remove from the market concentrated ingestible fluoride prescription drug products for children, citing safety concerns and a lack of for...

latest-news-card-1
Human Drugs

Assertio Pays $3.6 Million Over Improper Marketing

Assertio Therapeutics agrees to pay $3.6 million to resolve claims that it violated the False Claims Act by causing the submission of false claims abo...

latest-news-card-1
Human Drugs

Thermosome Gets Orphan Status on Sarcoma Drug

FDA grants Thermosome an orphan drug designation for THE001 and its use in treating soft tissue sarcomas.

latest-news-card-1
Human Drugs

Zepbound Beats Wegovy in Trial: Lilly

Eli Lillys Zepbound (tirzepatide) demonstrates significantly greater weight loss than Novo Nordisks Wegovy (semaglutide) in a head-to-head trial of th...

latest-news-card-1
Human Drugs

FDA Pulled Into Drug Pricing Fray

A new Trump administration executive order on drug pricing is moving FDA into pricing aspects to help lower drug costs by offering incentives and leve...